These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12975637)
1. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Fernandez-Real JM; Broch M; Vendrell J; Ricart W Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637 [TBL] [Abstract][Full Text] [Related]
2. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441 [TBL] [Abstract][Full Text] [Related]
3. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. Fernandez-Real JM; Pugeat M; Grasa M; Broch M; Vendrell J; Brun J; Ricart W J Clin Endocrinol Metab; 2002 Oct; 87(10):4686-90. PubMed ID: 12364459 [TBL] [Abstract][Full Text] [Related]
4. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417 [TBL] [Abstract][Full Text] [Related]
6. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects. Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545 [TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance. Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults. Ho RC; Davy KP; Hickey MS; Melby CL Cytokine; 2005 Apr; 30(1):14-21. PubMed ID: 15784408 [TBL] [Abstract][Full Text] [Related]
10. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study. Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040 [TBL] [Abstract][Full Text] [Related]
11. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. Fernández-Real JM; López-Bermejo A; Casamitjana R; Ricart W J Clin Endocrinol Metab; 2003 Jun; 88(6):2714-8. PubMed ID: 12788878 [TBL] [Abstract][Full Text] [Related]
12. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity. Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects. Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687 [TBL] [Abstract][Full Text] [Related]
14. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Fernandez-Real JM; Lainez B; Vendrell J; Rigla M; Castro A; Peñarroja G; Broch M; Pérez A; Richart C; Engel P; Ricart W Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E952-9. PubMed ID: 11882518 [TBL] [Abstract][Full Text] [Related]
15. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects. López-Bermejo A; Hernández-Aguado I; Vera IJ; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM Thromb Haemost; 2007 Feb; 97(2):240-4. PubMed ID: 17264953 [TBL] [Abstract][Full Text] [Related]
16. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Di Rocco P; Manco M; Rosa G; Greco AV; Mingrone G Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644 [TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Corica F; Allegra A; Corsonello A; Buemi M; Calapai G; Ruello A; Nicita Mauro V; Ceruso D Int J Obes Relat Metab Disord; 1999 Apr; 23(4):355-60. PubMed ID: 10340812 [TBL] [Abstract][Full Text] [Related]
18. Plasma soluble tumor necrosis factor-alpha receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women. Fernández-Real JM; Gutierrez C; Vendrell J; Casamitjana R; Ricart W Eur J Endocrinol; 2000 Aug; 143(2):235-41. PubMed ID: 10913943 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Molina A; Vendrell J; Gutiérrez C; Simón I; Masdevall C; Soler J; Gómez JM Obes Surg; 2003 Aug; 13(4):615-21. PubMed ID: 12935365 [TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Fernández-Real JM; Vendrell J; Ricart W; Broch M; Gutiérrez C; Casamitjana R; Oriola J; Richart C Diabetes Care; 2000 Jun; 23(6):831-7. PubMed ID: 10841005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]